TP53 and cancer: The dysregulation of the miR-34 family in somatic cells, notably observed in cancers like Merkel cell carcinoma, suggests its role as a tumor suppressor through involvement in tumor-associated processes like epithelial-mesenchymal transition and the p53 network [37, 38, 52, 53].